Stifel Financial Corp boosted its holdings in Concentrix Co. (NASDAQ:CNXC - Free Report) by 119.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 79,394 shares of the company's stock after buying an additional 43,263 shares during the period. Stifel Financial Corp owned approximately 0.12% of Concentrix worth $3,435,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC raised its holdings in Concentrix by 81.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 638 shares of the company's stock valued at $28,000 after acquiring an additional 286 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Concentrix by 159.6% during the fourth quarter. Venturi Wealth Management LLC now owns 797 shares of the company's stock worth $34,000 after purchasing an additional 490 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Concentrix by 58.7% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,201 shares of the company's stock worth $52,000 after purchasing an additional 444 shares in the last quarter. KBC Group NV lifted its stake in shares of Concentrix by 68.3% during the fourth quarter. KBC Group NV now owns 2,008 shares of the company's stock valued at $87,000 after acquiring an additional 815 shares during the period. Finally, Sterling Capital Management LLC boosted its stake in Concentrix by 49.7% in the fourth quarter. Sterling Capital Management LLC now owns 2,817 shares of the company's stock valued at $122,000 after acquiring an additional 935 shares during the last quarter. 90.34% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, CEO Christopher A. Caldwell purchased 1,000 shares of the business's stock in a transaction on Monday, April 21st. The shares were acquired at an average price of $46.00 per share, with a total value of $46,000.00. Following the completion of the transaction, the chief executive officer now owns 303,362 shares of the company's stock, valued at $13,954,652. The trade was a 0.33 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Cormac J. Twomey sold 500 shares of the company's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $55.31, for a total value of $27,655.00. Following the sale, the executive vice president now owns 39,130 shares in the company, valued at approximately $2,164,280.30. The trade was a 1.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 30,444 shares of company stock valued at $1,481,628 in the last three months. Insiders own 3.20% of the company's stock.
Concentrix Stock Up 0.9 %
Shares of CNXC opened at $51.10 on Friday. The firm's 50 day moving average is $48.09 and its 200-day moving average is $46.38. Concentrix Co. has a 12 month low of $36.28 and a 12 month high of $77.00. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of $3.26 billion, a PE ratio of 13.77, a P/E/G ratio of 0.63 and a beta of 0.51.
Concentrix (NASDAQ:CNXC - Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported $2.79 EPS for the quarter, beating the consensus estimate of $2.58 by $0.21. Concentrix had a net margin of 2.61% and a return on equity of 16.67%. The firm had revenue of $2.37 billion for the quarter, compared to analyst estimates of $2.37 billion. During the same period last year, the firm earned $2.57 EPS. The business's quarterly revenue was down 1.3% compared to the same quarter last year. Equities research analysts forecast that Concentrix Co. will post 10.11 EPS for the current year.
Concentrix Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 6th. Stockholders of record on Friday, April 25th will be paid a dividend of $0.3328 per share. This represents a $1.33 annualized dividend and a dividend yield of 2.60%. The ex-dividend date of this dividend is Friday, April 25th. Concentrix's payout ratio is currently 33.33%.
Analysts Set New Price Targets
A number of research firms have issued reports on CNXC. Bank of America boosted their target price on Concentrix from $58.00 to $59.00 and gave the company a "neutral" rating in a research note on Thursday, March 27th. Barrington Research lowered their target price on shares of Concentrix from $70.00 to $54.00 and set an "outperform" rating on the stock in a report on Monday, March 24th. Finally, Canaccord Genuity Group dropped their price objective on Concentrix from $100.00 to $80.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Concentrix presently has an average rating of "Buy" and an average target price of $65.75.
Get Our Latest Stock Analysis on CNXC
About Concentrix
(
Free Report)
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Further Reading
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Co. (NASDAQ:CNXC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.